First human test for new celiac disease detection method begins
Diagnosis
Recruiting now
This is a very early safety study to test a potential new diagnostic tool called HB-2121 for celiac disease. Researchers will give a single dose to 18 adults (some with celiac disease, some healthy) and monitor them for 30 days to check for side effects and see how the body proce…
Phase: PHASE1 • Sponsor: Nielsen Fernandez-Becker • Aim: Diagnosis
Last updated Mar 30, 2026 14:29 UTC